Bayer recalls one lot of cancer drug Vitrakvi due to contamination

Posted on:
Key Points

Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019..

Nov 17 (Reuters) - Bayer (BAYGn.DE) said on Friday it was voluntarily recalling one lot of its cancer drug Vitrakvi in the U.S. due to the presence of microbial contamination...

The recalled lot was distributed to wholesalers and specialty pharmacies in the U.S. between Jan. 3 and Feb. 13 this year...